A detailed history of Sterling Wealth Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Sterling Wealth Management, Inc. holds 2,966 shares of ABBV stock, worth $527,977. This represents 0.22% of its overall portfolio holdings.

Number of Shares
2,966
Previous 2,964 0.07%
Holding current value
$527,977
Previous $508 Million 15.2%
% of portfolio
0.22%
Previous 0.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $327 - $398
2 Added 0.07%
2,966 $586 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $17,646 - $20,606
114 Added 4.0%
2,964 $508 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $319 - $364
2 Added 0.07%
2,850 $519 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $391,884 - $441,354
2,848 New
2,848 $441 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sterling Wealth Management, Inc. Portfolio

Follow Sterling Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sterling Wealth Management, Inc. with notifications on news.